[Answered] Babies who inherit blue/blue or blue/green genes for eye color do NOT have melanocytes in their ...

This topic contains a solution. Click here to go to the answer

Author Question: Babies who inherit blue/blue or blue/green genes for eye color do NOT have melanocytes in their ... (Read 238 times)

Pineappleeh

Hero Member
Posts: 585

on: Jun 27, 2018

Babies who inherit blue/blue or blue/green genes for eye color do NOT have melanocytes in their irises.

Indicate whether the statement is true or false

Question 2

This procedure involves the use of a laser to reshape the cornea and correct vision.

A. LP
B. ALS
C. LASIK
D. ADHD

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

fwbard

Sr. Member
Posts: 325

Reply #1 on: Jun 27, 2018

Answer to Question 1

TRUE

Answer to Question 2

C

Pineappleeh

Member
Posts: 585

Reply 2 on: Jun 27, 2018

Gracias!

essyface1

Member
Posts: 347

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.